GlassScriptPhysician profile
Peter Michael Loisides
NPI 1679647838
$1,571.53
in general payments reported to CMS, 2019-2025
20 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $53.63 · 2021: $88.21 · 2022: $588 · 2023: $399 · 2024: $151 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $736.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $371.05 | 2022-2024 | Urolift |
| Procept Biorobotics Corporation | $340.40 | 2022-2025 | Aquabeam Robotic System |
| Endo Pharmaceuticals INC. | $194.59 | 2019-2023 | Xiaflex |
| Tolmar Pharmaceuticals, INC. | $125.41 | 2021-2022 | |
| Accord Healthcare, INC. | $95.94 | 2023-2025 | |
| Olympus America INC. | $69.59 | 2024-2025 | Itind System |
| Ferring Pharmaceuticals INC. | $61.09 | 2025 | Adstiladrin |
| Glaxosmithkline, LLC. | $55.02 | 2023-2024 | Benlysta |
| Abbvie INC. | $50.14 | 2022 | |
| Bluewind Medical | $29.32 | 2024 | Revi |
| Progenics Pharmaceuticals, INC. | $26.26 | 2023 | Pylarify |
| Halozyme INC | $22.83 | 2023 | |
| Edap Technomed INC | $22.00 | 2024 | |
| Endo USA, INC. | $20.30 | 2025 | Xiaflex |
| Boston Scientific Corporation | $16.62 | 2023 | Rezum Generator |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $14.98 | 2019 | |
| Astellas Pharma US INC | $14.89 | 2020 | |
| Axonics, INC. | $14.43 | 2023 | Axonics, Bulkamid |
| Myriad Genetic Laboratories, INC. | $14.34 | 2021 | |
| Coloplast Corp | $12.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Loisides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.